COVID-19 trials registries data warehouse

https://lbctr.moph.gov.lb/Trials/Details/4658

Rasha Hamra

rashahamra@yahoo.com

2020-04-23 00:00:00

Not recruiting

RCT

Randomized

Parallel

Open label

unclear

Treatment

Eligibility: consenting adults (age =18) hospitalised with definite COVID-19, not already receiving any of the study drugs, without known allergy or contra-indications to any of them (in the view of the physician responsible for their care), and without anticipated transfer within 72 hours to a non-study hospital. Patients invited to join the study will be those who are admitted to a collaborating hospital, no wider recruitment efforts are expected.

Exclusion from study entry: Patients will not be randomised if, in the view of the randomising doctor, ANY of the AVAILABLE study drugs are contra-indicated (eg, because of patient characteristics, chronic liver or heart disease, or some concurrent medication).

2

WHO

18

99

Lebanon

Moderate/severe/critical disease at enrollment

5: Moderate/severe/critical disease at enrollment

1000

Name: All-cause mortality; subdivided by severity of disease at the time of randomisation;Timepoints: At discharge or death;Measure: Discharge date or Cause of death

Phase 3

[{"arm_notes": "No online access, Solidarity trial Lebanon", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "No online access, Solidarity trial Lebanon", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]